Global Exosomes Market Size To Worth USD 1710.22 Million by 2033 | CAGR of 28.64%
Category: HealthcareGlobal Exosomes Market Size Worth USD 1710.22 Million by 2033
According to a research report published by Spherical Insights & Consulting, the Global Exosomes Market Size is Expected to Grow from USD 137.81 Million in 2023 to USD 1710.22 Million by 2033, at a CAGR of 28.64% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 251 pages with 116 Market data tables and figures & charts from the report on the "Global Exosomes Market Size, Share, and COVID-19 Impact Analysis, By Products and Services (Kits and Reagents, Instruments, and Services), By Indication (Neurodegenerative Diseases, Cardiovascular Diseases, Cancer, Infectious Diseases, and Others), By Application (Therapeutic and Diagnostic), By End-User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology, and Academic and Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033" Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/exosomes-market
The exosomes market involves the research, development, production, and sale of tiny vesicles secreted by cells for intercellular communication. These nano-sized vesicles carry specific cargos and have potential as non-invasive diagnostic biomarkers and therapeutic nanocarriers. The industry is driven by advancements in exosome isolation technologies, expanded applications, and rising cancer rates. Exosomes have the potential for diagnosing and monitoring diseases like infectious diseases, neurodegenerative disorders, cancer, and cardiovascular diseases, with mergers and acquisitions expected to accelerate growth. The exosomes market is expanding due to the rise in neurological disorders worldwide, driven by longer life expectancy, increased infection exposure, and sedentary lifestyles. Technological advancements, clinical trials, and regulatory support are driving growth, along with patient advocacy. However, the high cost of production and treatment expenditures may hinder market growth.
The kits and reagents segment held the greatest share in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the products and services, the global exosomes market is categorized as kits and reagents, instruments, and services. Among these, the kits and reagent segment held the greatest share in 2023 and is predicted to grow at a significant CAGR during the predicted period. Kits and reagents are crucial tools for exosome research, enabling isolation, characterization, and analysis. They are essential for exosome-related experiments, drug development, and treatment development, making them a significant part of the exosome market.
The cancer segment held the highest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe.
Based on the indication, the global exosomes market is categorized as neurodegenerative diseases, cardiovascular diseases, cancer, infectious diseases, and others. Among these, the cancer segment held the highest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe. Exosome-based liquid biopsies may identify cancer earlier than conventional techniques, increasing patient survival rates and treatment outcomes, and driving segment growth in cancer diagnosis and therapy.
The therapeutic segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the application, the global exosomes market is categorized as therapeutic and diagnostic. Among these, the therapeutic segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. Exosomes hold significant potential in various therapeutic fields, including cancer, cardiovascular disorders, neurology, and regenerative medicine, targeting specific cells and tissues, carrying bioactive substances, and altering cellular function.
The pharmaceutical and biotechnology segment held the greatest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe.
Based on the end-user, the global exosomes market is categorized into hospitals and diagnostic centers, pharmaceutical and biotechnology, and academic and research institutes. Among these, the pharmaceutical and biotechnology segment held the greatest share in 2023 and is predicted to grow at a significant CAGR throughout the projected timeframe. Significant investment, innovation, and research are being made in developing exosome-based therapeutics for various diseases, including cancer, neurological disorders, cardiovascular diseases, and infectious diseases, with potential for tissue regeneration and wound healing.
North America is expected to hold the greatest share of the global exosomes market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global exosomes market over the forecast period. The U.S. exosomes market is anticipated to expand in North America due to government funding, chronic disease incidence, targeted therapies, regenerative medicine research, and increasing disease prevalence.
Asia Pacific is predicted to hold the fastest-growing region of the global exosomes market throughout the estimated period. China and Japan are leading the market in exosome-based therapies due to expanding biotechnological capabilities and rising healthcare expenditures, driven by growing chronic disease incidence and proactive regulatory environments.
Major key players in the global exosomes market are Lonza, RoosterBio, Inc., ThermoFisher Scientific, Inc., Abcam, Hitachi Chemical Diagnostic, Bio-Tech Corp, Diagenode, Clara Biotech, Beckman Coulter, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In June 2024, Vytrus developed the plant exosomes for skin and hair care purposes derived from the Curcuma longa and Centella asiatica plant stem cell cultures. Curcuma longa exosomes improve skin hydration, hair density, and hair loss delay, while Centella asiatica encapsulates growth factors, proteins, and peptides for potential health benefits.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global exosomes market based on the below-mentioned segments:
Global Exosomes Market, By Products and Services
- Kits and Reagents
- Instruments
- Services
Global Exosomes Market, By Indication
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Others
Global Exosomes Market, By Application
- Therapeutic
- Diagnostic
Global Exosomes Market, By End-User
- Hospital and Diagnostic Centers
- Pharmaceutical and Biotechnology
- Academic and Research Institute
Global Exosomes Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?